Featured Posts
Colleagues,
WHO has released the Full Value of Improved Influenza Vaccines Assessment (FVIVA), looking at the potential health, economic and policy impacts of next-generation influenza vaccines that offer broader and longer-lasting protection than current seasonal products.
Some key takeaways that...
Posts
Learning agenda on hepatitis B birth dose vaccine delivery in Africa
Insights and recommendations to improve timely administration
Wednesday 4 March at 16:00–17:30 EAT | 14:00–15:30 CET | 8:00–9:30 EST
Chronic hepatitis B affects 254 million people globally, with the highest burden in low‑ and m...
Good day,
We are looking for free or WHO-supported tools to manage preventive maintenance (PM) for vaccine cold chain equipment. Our goals are:
Schedule routine maintenance for refrigerators, cold rooms, and freezers
Track asset inventory and maintenance history
Align documentation w...
I believe that IPV vaccine is avaliable with VVM 14 and 30. VVM 14 color changes faster, can we use IPV with VVM 30 for immunization program? Any price difference between VVM 14 and 30?
Can someone help to respond?...
Which indicator is best to calculate drop out rate for Penta 1 to 3
1. MR 1st dose to Penta 3rd dose
2. Penta 1st dose to Penta 3rd dose ...
I believed even countries maintaining high routine immunization coverage for OPV and IPV also detected cVDPV 3 or Type I poliovirus in enviromental sample, so whether cVDPV or type 1 polio virus is imported or mutated originated strain within the country.
1. If it is imported what could be the mode...
Dear Colleagues,
We would like to introduce you our upcoming Virtual KLIC Innovation Agora series - vKIA #09: Climate-smart vaccine delivery: Resilient systems for unpredictable climate.
This event promises to bring together the brightest minds in global health innovation for an...
WHO Immunization Devices prequalification (WHO IMD-PQS) is delighted to announce the opening of the NEW WHO e-Prequalification System (ePQS) for immunization device prequalification and a NEW website and catalogue of prequalified products for WHO Immunization Devices. WHO eP...
Some countries introduced one dose of IPV in 2015, switched from tOPV to bOPV in 2016, and introduced a second dose of IPV in 2021. These countries are at low risk for polio importation or transmission. Can these countries discontinue the use of bOPV and switch to IPV only for routine immunization?...
New OPV birth dose
Those countries maintaining polio-free status for the last ten years and sustaining OPV3 coverage of more than 95%, and that have introduced two doses of IPV vaccine into the routine immunization schedule. Some countries are still giving the OPV zero dose. Do they need to give OPV zero mandatorily o...
For people who got chickenpox at a young age, are these people at high risk of getting herpes zoster when they become older?...
Wednesday, June 25, 2025 | 14:00 to 15:30 UTC |
Interpretation is available in both English and French.
Register Today: Meeting Registration Link
Join us on June 25, 2025, for a webinar on ZIP, Gavi’s Humanitarian Partnerships, hosted by CORE Group and featuring the International Rescue...
Dear All
The March 2025 SAGE meeting report has been officially published today and is now available on the SAGE website.
Strategic Advisory Group of Experts on Immunization (SAGE)
With best regards,
Jaya on behalf of the SAGE Secretariat...
Is there an updated guideline for the Thermostability of vaccines 1998 (attached)?
...
Dear TechNet community,
The World Bank is hosting a webinar on April 8, 2025 on looking at how to engage religious and community leaders to advance HPV vaccination. In case this is of interest, I thought I’d share the invitation link if you’d like to pass it along to your networks! Simultaneou...
You are invited to join this webinar that will take a deep dive into immunization service delivery and supply chain data, presented by JSI and hosted by TechNet.
Tuesday, March 4 at 9:00 AM EST/3:00 PM CET/5:00 PM EAT
Lack of accurate consumption data, and true wastage data may be contributing to ...
WHO is looking for new experts to join our Product Development for Vaccines Advisory Committee (PDVAC) (we have up to 6 spots opening up).
WHO welcomes expressions of interest from scientists, public health professionals, pediatricians, and regulators with expertise the following areas:
Infectio...
WHO is seeking partners to conduct pre-implementation research for measles and rubella microarray patches (MR-MAPs). This RFP focuses on advancing critical research to optimize the introduction and scale-up of this innovative vaccine delivery technology.🔍 Key Areas of Research:✅ Caregiver and vaccin...
Dear colleagues,
With GAVI's recent announcement incorporating the category of TPVS active vaccine carriers into the Cold Chain Equipment Optimization Platform (CCEOP), I wanted to open up a discussion to gather your inputs and suggestions on this development.
As immunization professionals, we are...
The World Vaccine Congress Washington is the largest, most established meeting dedicated to vaccines. It serves as a platform for leading scientists, researchers, policymakers, biotech companies, and pharmaceutical leaders to collaborate, discuss, and drive advancements throughout the entire vaccine...
New PCV 13 for adult
Can PCV 13 vaccine be given to adult, what could be nos of doses and schedule /interval vs effectiness...
There are no discussions available here currently